127 related articles for article (PubMed ID: 33976364)
1. Response to Lee et al: Toward a unifying entity that encompasses most, but perhaps not all, inflammatory leiomyosarcomas and histiocyte-rich rhabdomyoblastic tumors.
Folpe AL
Mod Pathol; 2021 Jul; 34(7):1439. PubMed ID: 33976364
[No Abstract] [Full Text] [Related]
2. Toward a unifying entity that encompasses most, but perhaps not all, inflammatory leiomyosarcomas and histiocyte-rich rhabdomyoblastic tumors.
Lee JC; Li WS; Kao YC; Chung YC; Huang HY
Mod Pathol; 2021 Jul; 34(7):1434-1438. PubMed ID: 33762681
[No Abstract] [Full Text] [Related]
3. Inflammatory rhabdomyoblastic tumor with progression to high-grade rhabdomyosarcoma.
Geiersbach K; Kleven DT; Blankenship HT; Fritchie K; Folpe AL
Mod Pathol; 2021 May; 34(5):1035-1036. PubMed ID: 33758326
[No Abstract] [Full Text] [Related]
4. Pulmonary "Inflammatory Leiomyosarcomas" Are Indolent Tumors With Diploid Genomes and No Convincing Rhabdomyoblastic Differentiation.
Kao YC; Kuo CT; Kuo PY; Huang HY; Lu TP; Hsieh TH; Fletcher CDM; Lee JC
Am J Surg Pathol; 2022 Mar; 46(3):424-433. PubMed ID: 35175969
[TBL] [Abstract][Full Text] [Related]
5. Histiocyte-rich rhabdomyoblastic tumor: a report of two cases and a review of the differential diagnoses.
Bourgeau M; Martinez AP
Virchows Arch; 2021 Feb; 478(2):367-373. PubMed ID: 32514584
[TBL] [Abstract][Full Text] [Related]
6. "Inflammatory Leiomyosarcoma" and "Histiocyte-rich Rhabdomyoblastic Tumor": a clinicopathological, immunohistochemical and genetic study of 13 cases, with a proposal for reclassification as "Inflammatory Rhabdomyoblastic Tumor".
Cloutier JM; Charville GW; Mertens F; Sukov W; Fritchie K; Perry KD; Edgar M; Rowsey RA; Folpe AL
Mod Pathol; 2021 Apr; 34(4):758-769. PubMed ID: 33318583
[TBL] [Abstract][Full Text] [Related]
7. T-cell/histiocyte-rich large B-cell lymphoma is a disseminated aggressive neoplasm: differential diagnosis from Hodgkin's lymphoma.
Fraga M; Sánchez-Verde L; Forteza J; García-Rivero A; Piris MA
Histopathology; 2002 Sep; 41(3):216-29. PubMed ID: 12207783
[TBL] [Abstract][Full Text] [Related]
8. T-cell/histiocyte-rich large B-cell lymphoma shows transcriptional features suggestive of a tolerogenic host immune response.
Van Loo P; Tousseyn T; Vanhentenrijk V; Dierickx D; Malecka A; Vanden Bempt I; Verhoef G; Delabie J; Marynen P; Matthys P; De Wolf-Peeters C
Haematologica; 2010 Mar; 95(3):440-8. PubMed ID: 19797726
[TBL] [Abstract][Full Text] [Related]
9. Splenic micronodular T-cell/histiocyte-rich large B-cell lymphoma.
Kan E; Levy I; Benharroch D
Ann Diagn Pathol; 2008 Aug; 12(4):290-292. PubMed ID: 18620998
[TBL] [Abstract][Full Text] [Related]
10. Hemophagocytic Lymphohistiocytosis Secondary to T Cell/Histiocyte-rich Large B Cell Lymphoma in an Adolescent Male.
Metts JL; Park SI; Briones MA; Keller FG
Pediatr Dev Pathol; 2018; 21(1):95-99. PubMed ID: 29187030
[TBL] [Abstract][Full Text] [Related]
11. 'T-cell-rich large B-cell lymphoma'-'histiocyte-rich, T-cell-rich large B-cell lymphoma'-'T-cell/histiocyte-rich large B-cell lymphoma': will we ever see the wood for the trees?
De Wolf-Peeters C; Achten R
Histopathology; 2002 Sep; 41(3):269-71. PubMed ID: 12207791
[No Abstract] [Full Text] [Related]
12. CD5+ T-cell/histiocyte-rich large B-cell lymphoma.
Chang CC; Bunyi-Teopengco E; Eshoa C; Chitambar CR; Kampalath B
Mod Pathol; 2002 Oct; 15(10):1051-7. PubMed ID: 12379751
[TBL] [Abstract][Full Text] [Related]
13. Lymphomas of true histiocytic origin. Expression of different phenotypes in so-called true histiocytic lymphoma and malignant histiocytosis.
Hsu SM; Ho YS; Hsu PL
Am J Pathol; 1991 Jun; 138(6):1389-404. PubMed ID: 1647137
[TBL] [Abstract][Full Text] [Related]
14. Macrophages in T cell/histiocyte rich large B cell lymphoma strongly express metal-binding proteins and show a bi-activated phenotype.
Hartmann S; Tousseyn T; Döring C; Flüchter P; Hackstein H; Herreman A; Ponzoni M; de Wolf-Peeters C; Facchetti F; Gascoyne RD; Küppers R; Steidl C; Hansmann ML
Int J Cancer; 2013 Dec; 133(11):2609-18. PubMed ID: 23686423
[TBL] [Abstract][Full Text] [Related]
15.
Schuhmacher B; Bein J; Rausch T; Benes V; Tousseyn T; Vornanen M; Ponzoni M; Thurner L; Gascoyne R; Steidl C; Küppers R; Hansmann ML; Hartmann S
Haematologica; 2019 Feb; 104(2):330-337. PubMed ID: 30213827
[TBL] [Abstract][Full Text] [Related]
16. T-cell/histiocyte-rich large B-cell lymphoma with zonal expansion of fibroblastic reticulum cells and infiltration by a subpopulation of myeloperoxidase positive histiocytes.
Suárez-Vilela D; Izquierdo FM; Riera-Velasco JR; Burgo PM
Pathol Res Pract; 2014 Dec; 210(12):1167-70. PubMed ID: 25042387
[No Abstract] [Full Text] [Related]
17. T-cell/histiocyte-rich large B-cell lymphoma: a distinct clinicopathologic entity.
Achten R; Verhoef G; Vanuytsel L; De Wolf-Peeters C
J Clin Oncol; 2002 Mar; 20(5):1269-77. PubMed ID: 11870169
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological analysis and genomic profiling of a rare histiocyte-rich rhabdomyoblastic tumor: A case report.
Xia Y; Li Y; Gong P; Jiang H; Zhang X
Medicine (Baltimore); 2021 Jun; 100(24):e26105. PubMed ID: 34128847
[TBL] [Abstract][Full Text] [Related]
19. From a pathologist's point of view: Histiocytic cells in Hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma.
Hartmann S
Pathol Res Pract; 2015 Dec; 211(12):901-4. PubMed ID: 26596262
[TBL] [Abstract][Full Text] [Related]
20. T cell/histiocyte-rich large B-cell lymphoma: an update on its biology and classification.
Tousseyn T; De Wolf-Peeters C
Virchows Arch; 2011 Dec; 459(6):557-63. PubMed ID: 22081105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
